Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression
Objective: Brain-derived neurotrophic factor (BDNF) levels are decreased in individuals with depression and increase following antidepressant treatment. The objective of this study is to compare pre- and post-treatment serum BDNF levels in patients with drug-resistant major depressive disorder (MDD)...
Main Authors: | Laura eGedge, Ashley eBeaudoin, Lauren eLazowski, Regina edu Toit, Ruzica eJokic, Roumen eMilev |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-02-01
|
Series: | Frontiers in Psychiatry |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpsyt.2012.00012/full |
Similar Items
-
Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial: the work of M. Alex Wollmer, et al. (2014)
by: Roumen eMilev
Published: (2015-04-01) -
The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
by: Caroline J. K. Wallace, et al.
Published: (2021-02-01) -
Add-on quetiapine for bipolar depression: twelve months open label prospective trial
by: Abraham Gaby, et al.
Published: (2006-02-01) -
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
by: Chinna Meyyappan, Arthi, et al.
Published: (2020-06-01) -
Systematic review of probiotics as an adjuvant treatment for psychiatric disorders
by: Evan Forth, et al.
Published: (2023-02-01)